Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trial. [PDF]
Gallo G, Volterrani M, Tocci G, Volpe M.
europepmc +1 more source
Medication non-adherence and apparent treatment-resistant hypertension. [PDF]
Jenkins S +3 more
europepmc +1 more source
The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension. [PDF]
Masi S +7 more
europepmc +1 more source
Distal radial artery access for renal denervation in resistant hypertension: a case report. [PDF]
Zhao Y, Du Y, Tang Y, Yu M, Gao L.
europepmc +1 more source
Association of Metabolic Score for Insulin Resistance With Resistant Hypertension and Hypertension in Obstructive Sleep Apnea. [PDF]
Xin J +5 more
europepmc +1 more source
Resistant hypertension: Epidemiology, mechanisms and contemporary therapeutic strategies. [PDF]
Sharma R +8 more
europepmc +1 more source
GWAS and Replication Analysis of Apparent Treatment-Resistant Hypertension. [PDF]
Ebinger JE +8 more
europepmc +1 more source
Contemporary Prevalence and Treatment Patterns Among US Adults With Apparent Treatment-Resistant Hypertension. [PDF]
Earle WB +5 more
europepmc +1 more source
[Primary aldosteronism in resistant hypertension unmasked by a thiazide-induced severe hypokalaemia]. [PDF]
Del Rey Fernández AJ +2 more
europepmc +1 more source
Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension. [PDF]
Capriello I, Dömling A.
europepmc +1 more source

